Cardiometabolic Risk Factors Superior to FIB4 in Identifying Adults at Risk for NAFLD with Fibrosis

被引：0
|
作者：
Leiva, Eddison Godinez
Sharma, Anu
Kalavalapalli, Srilaxmi
Rocha, Andrea Ortiz
Saenz, Enrique Valdez
Mohseni, Yasmine
Pardo, Nathaly Cuervo
Rosenberg, Jens T.
Grajo, Joseph R.
Barb, Diana
Cusi, Kenneth
机构：
来源：
DIABETES | 2024年 / 73卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.2337/db24-1352-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1352-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ASSOCIATION OF FIB4 SCORE WITH DISEASE PROGRESSION IN REAL-WORLD POPULATIONS DIAGNOSED WITH NAFLD/NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE
    Lai, Michelle
    Broestl, Jeremy
    Frick, Andrew
    Haubrich, Richard
    Koch, Bruce
    Milligan, Scott
    Natha, Macky
    Younossi, Zobair M.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2020, 158 (06) : S1416 - S1416
  • [22] Risk assessment and correlation of MAFLD and FIB4 index in patients with type 2 diabetes
    Polisetti, S.
    Tippisetty, S.
    Seshadri, K.
    Reddy, S. A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [23] NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk
    Lonardo, Amedeo
    Nascimbeni, Fabio
    Ballestri, Stefano
    HEPATOLOGY, 2017, 65 (06) : 2122 - +
  • [24] The prognosis is impaired in NAFLD patients with diabetes despite negative FIB4 <1.30
    Boursier, Jerome
    Ekstedt, Mattias
    Gomez, Manuel Romero
    Moreau, Clemence
    Bonacci, Martin
    Cure, Sandrine
    Trylesinski, Aldo
    Hagstrom, Hannes
    JOURNAL OF HEPATOLOGY, 2021, 75 : S557 - S558
  • [25] The effects of obesity phenotypes on NAFLD and related cardiometabolic risk factors in children
    Meng, Linghui
    Mi, Jie
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S117 - S117
  • [26] Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
    Nones, Rodrigo Bremer
    Ivantes, Claudia Pontes
    Alves Pedroso, Maria Lucia
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (03): : 276 - 281
  • [27] NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk Reply
    Joo, Eun-Jeong
    Chang, Yoosoo
    Ryu, Seungho
    HEPATOLOGY, 2017, 65 (06) : 2123 - +
  • [28] The FIB4 Index and M2BPGi Are the Independent Risk Factors for Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma.
    Ninomiya, Masashi
    Inoue, Jun
    Kakazu, Eiji
    Iwata, Tomoaki
    Takai, Satoshi
    Nakamura, Takuya
    Sano, Akitoshi
    Masamune, Atsushi
    HEPATOLOGY, 2018, 68 : 851A - 852A
  • [29] High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes
    Haruka Saito
    Hayato Tanabe
    Akihiro Kudo
    Noritaka Machii
    Moritake Higa
    Satoshi Yamaguchi
    Gulinu Maimaituxun
    Kazumichi Abe
    Atsushi Takahashi
    Kenichi Tanaka
    Koichi Asahi
    Hiroaki Masuzaki
    Hiromasa Ohira
    Junichiro J. Kazama
    Michio Shimabukuro
    Scientific Reports, 11
  • [30] Use of FIB4 as a screening test in the bariatric population instead of the NAFLD fibrosis score reduces referral rate to hepatology without reducing identification of significant fibrosis: a retrospective audit
    Carbonell, Michael
    Lennie, Craig
    Davison, Nuala
    Gomez, Naim Fakih
    Greener, Veronica
    Abeles, R. Daniel
    JOURNAL OF HEPATOLOGY, 2024, 80 : S553 - S553
12345